Table 2.
Clinical trials based on stem cell in androgenetic alopecia
Stem cell source | Time | Recruitment | Method | Results | Reference |
---|---|---|---|---|---|
Adipose tissue | 12 weeks | 27 | Application of AAPE™ with micro-needle roller | Hair density increased from 105.4 to 122.7 hairs/cm2 (P < 0.001); Hair thickness increased from 57.5 mum to 64.0 mum (P < 0.001) | [75] |
Hair follicles | 23 weeks | 21 | HFSCs injections 1 mL (0.2 mL·cm2) were administered to select areas of the scalp at a depth of 5 mm; Injections performed in two sessions spaced 60 days | 29% ± 5% increase in hair density for the treated area and less than a 1% increase in hair density for the placebo area | [63] |
Adipose tissue | 16 weeks | 38 | 130-mL topical solution, apply 2 mL of this solution to the hair loss area, twice every day for 16 weeks | Hair diameter after 16 weeks was observed in IG compared with that in CG, with the total percentage change from baseline of 14.2% vs 6.3% | [76] |
Hair follicles | 4 months | 46 | Apply one vial (5 mL) of the product on clean and dry scalp, apply every day for 5 consecutive days, stop the treatment for 2 days and then continue the application | After 2 and 4 months of treatment, the anagen rate was increased by 6.8% and 10.7%, respectively. Hair resistance to traction was decreased by 29.6% and 46.8% | [77] |
Umbilical cord blood | 3 months | 15 | The investigational product was transported frozen to the study site, thawed just before use, and applied using a 1.5 mm derma roller by the study investigator | Patient feedback demonstrated that 92% agreed that the investigational product was effective and were highly satisfied with the treatment after 3 months. Clinical evaluation indicated that 5–10% of young patients showed improvement in the control of graying of hair | [78] |
Umbilical cord blood | 24 weeks | 87 | Be directed to use on hair and scalp by subject her/himself at home twice a day (in the morning and evening) for 24 week | Not found |